BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 32405079)

  • 1. Dynamic changes in routine blood parameters of a severe COVID-19 case.
    Lu G; Wang J
    Clin Chim Acta; 2020 Sep; 508():98-102. PubMed ID: 32405079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: A sentinel?
    Sun DW; Zhang D; Tian RH; Li Y; Wang YS; Cao J; Tang Y; Zhang N; Zan T; Gao L; Huang YZ; Cui CL; Wang DX; Zheng Y; Lv GY
    Clin Chim Acta; 2020 Sep; 508():122-129. PubMed ID: 32417210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.
    Fu J; Kong J; Wang W; Wu M; Yao L; Wang Z; Jin J; Wu D; Yu X
    Thromb Res; 2020 Aug; 192():3-8. PubMed ID: 32407937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China.
    Sun S; Cai X; Wang H; He G; Lin Y; Lu B; Chen C; Pan Y; Hu X
    Clin Chim Acta; 2020 Aug; 507():174-180. PubMed ID: 32339487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients.
    Yang AP; Liu JP; Tao WQ; Li HM
    Int Immunopharmacol; 2020 Jul; 84():106504. PubMed ID: 32304994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients.
    Urra JM; Cabrera CM; Porras L; Ródenas I
    Clin Immunol; 2020 Aug; 217():108486. PubMed ID: 32479985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of neutrophil-lymphocyte ratio and lymphocyte-monocyte ratio in the prognosis of type 2 diabetics with COVID-19.
    Liu G; Zhang S; Hu H; Liu T; Huang J
    Scott Med J; 2020 Nov; 65(4):154-160. PubMed ID: 32865157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort.
    Cheng B; Hu J; Zuo X; Chen J; Li X; Chen Y; Yang G; Shi X; Deng A
    Clin Microbiol Infect; 2020 Oct; 26(10):1400-1405. PubMed ID: 32622952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of peripheral blood differential counts in hospitalized patients with COVID-19.
    Pakos IS; Lo KB; Salacup G; Pelayo J; Bhargav R; Peterson E; Gul F; DeJoy R; Albano J; Patarroyo-Aponte G; Rangaswami J; Azmaiparashvili Z
    Eur J Haematol; 2020 Dec; 105(6):773-778. PubMed ID: 32794205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID-19): A multicenter, cross-sectional study.
    Peng J; Qi D; Yuan G; Deng X; Mei Y; Feng L; Wang D
    J Clin Lab Anal; 2020 Oct; 34(10):e23475. PubMed ID: 32681559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood routine test in mild and common 2019 coronavirus (COVID-19) patients.
    Djakpo DK; Wang Z; Zhang R; Chen X; Chen P; Antoine MMLK
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32725148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study.
    Mousavi SA; Rad S; Rostami T; Rostami M; Mousavi SA; Mirhoseini SA; Kiumarsi A
    Hematology; 2020 Dec; 25(1):383-388. PubMed ID: 33124971
    [No Abstract]   [Full Text] [Related]  

  • 13. Can COVID-19 Mortality be Predicted in the Emergency Room?
    Güneysu F; Guner NG; Erdem AF; Durmus E; Durgun Y; Yurumez Y
    J Coll Physicians Surg Pak; 2020 Sep; 30(9):928-932. PubMed ID: 33036676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic profile and clinical implications of hematological parameters in hospitalized patients with coronavirus disease 2019.
    Ding X; Yu Y; Lu B; Huo J; Chen M; Kang Y; Lou J; Liu Z
    Clin Chem Lab Med; 2020 Jul; 58(8):1365-1371. PubMed ID: 32441666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of serum amyloid A in patients with COVID-19.
    Cheng L; Yang JZ; Bai WH; Li ZY; Sun LF; Yan JJ; Zhou CL; Tang BP
    Infection; 2020 Oct; 48(5):715-722. PubMed ID: 32734556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis.
    Ghahramani S; Tabrizi R; Lankarani KB; Kashani SMA; Rezaei S; Zeidi N; Akbari M; Heydari ST; Akbari H; Nowrouzi-Sohrabi P; Ahmadizar F
    Eur J Med Res; 2020 Aug; 25(1):30. PubMed ID: 32746929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia.
    Zhou Y; Guo S; He Y; Zuo Q; Liu D; Xiao M; Fan J; Li X
    Front Cell Infect Microbiol; 2020; 10():322. PubMed ID: 32612961
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients.
    Elshazli RM; Toraih EA; Elgaml A; El-Mowafy M; El-Mesery M; Amin MN; Hussein MH; Killackey MT; Fawzy MS; Kandil E
    PLoS One; 2020; 15(8):e0238160. PubMed ID: 32822430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early.
    Tan C; Huang Y; Shi F; Tan K; Ma Q; Chen Y; Jiang X; Li X
    J Med Virol; 2020 Jul; 92(7):856-862. PubMed ID: 32281668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis.
    Li H; Xiang X; Ren H; Xu L; Zhao L; Chen X; Long H; Wang Q; Wu Q
    J Infect; 2020 Jun; 80(6):646-655. PubMed ID: 32277967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.